Live from the NIH registry
Studies recruiting near Columbia right now
Top 25 of 256 recruiting studies, sorted by proximity — each links to its official registry page
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
Hand Transplantation, Peripheral Nerve Injuries
N/A
Interventional 180 participants sought
University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Capital Region Southwest Campus — Jefferson City, Missouri (26.9 mi)
· Sponsor: SWOG Cancer Research Network
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
Mental Health Issue
N/A
Interventional 21,350 participants sought
University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: University of Virginia
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
University of Missouri Health Care — Columbia, Missouri (0.5 mi)
· Sponsor: Duke University
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Supratentorial Hemorrhage
N/A
Observational 500 participants sought
University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: Integra LifeSciences Corporation
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Urothelial Carcinoma, Urothelial Carcinoma Recurrent
N/A
Observational 400 participants sought
University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: UroGen Pharma Ltd.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
University of Missouri Children's Hospital — Columbia, Missouri (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Sleep as a Mechanism of Change in Alcohol Use
Insomnia, Alcohol; Harmful Use
N/A
Interventional 256 participants sought
University of Missouri-Columbia — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
MU Health - University Hospital/Ellis Fischel Cancer Center — Columbia, Missouri (0.5 mi)
· Sponsor: NRG Oncology
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Missouri Cancer Associates — Columbia, Missouri (0.5 mi)
· Sponsor: SCRI Development Innovations, LLC
Evaluation of Cognitive Behavioral Therapy for Insomnia (CBT-I) in Individuals With Mild Traumatic Brain Injury (mTBI)
Sleep Architecture, Mild Traumatic Brain Injury
N/A
Interventional 15 participants sought
University of Missouri-Columbia — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
Immediate Vs. Delayed Weight Bearing Postoperative Protocol in Diabetic Ankle Fractures
Ankle Fractures
N/A
Interventional 25 participants sought
University of Missouri Health System — Columbia, Missouri (0.5 mi)
· Sponsor: Kyle Schweser MD
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
University of Missouri Children's Hospital — Columbia, Missouri (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 3
Interventional 380 participants sought
University of Missouri Hospital /ID# 261553 — Columbia, Missouri (0.5 mi)
· Sponsor: AbbVie
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 3
Interventional 486 participants sought
MU Health - University Hospital/Ellis Fischel Cancer Center — Columbia, Missouri (0.5 mi)
· Sponsor: NRG Oncology
Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy
Lumbar Disc Herniation
Phase 4
Interventional 200 participants sought
Missouri Orthopaedic Institute — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
Phase 2
Interventional 186 participants sought
GSK Investigational Site — Columbia, Missouri (0.5 mi)
· Sponsor: ViiV Healthcare
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
Schizophrenia, Autism-Related Irritability
Phase 3
Interventional 400 participants sought
Local Institution - 0142 — Columbia, Missouri (0.5 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Non Small Cell Lung Cancer, Esophageal Cancer
N/A
Observational 320 participants sought
Harry S Truman Veterans Memorial Hospital — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
University of Missouri Children's Hospital — Columbia, Missouri (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Missouri Cardiovascular Specialist — Columbia, Missouri (0.5 mi)
· Sponsor: Novo Nordisk A/S
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
MU Health Care Goldschmidt Cancer Center — Jefferson City, Missouri (26.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)
Small-cell Lung Cancer, Brain Metastases
N/A
Observational 20 participants sought
University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Urothelial Cancer, Urinary Bladder Neoplasms
Phase 3
Interventional 390 participants sought
Missouri Cancer Associates — Columbia, Missouri (0.5 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
University of Missouri - Ellis Fischel — Columbia, Missouri (0.5 mi)
· Sponsor: SWOG Cancer Research Network